OneSource Specialty Pharma Q2 Net Profit Jumps 448% YoY to ₹57.5 Crore as Margins Expand
OneSource Specialty Pharma reports a 448% YoY surge in net profit to ₹57.5 crore for Q2 FY27, with operating margins climbing to 10.2% and revenue up 37% YoY.
CDMO
Latest CDMO stock news from NSE and BSE filings, 4 stories so far.
Production Started
Shilpa Medicare Commissions Integrated ADC Manufacturing Facility in Dharwad
Shilpa Medicare commissions a state-of-the-art ADC GMP manufacturing facility in Dharwad. The new plant enhances CDMO capabilities in the oncology space.
